Avantax Planning Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$18K	–	868
2018 Q3	$18K	Buy	+150	New	+$18K	﹤0.01%	730
2018 Q2	–	Sell	-10	Closed	-$1K	–	1011
2018 Q1	$1K	Buy	+10	New	+$1K	﹤0.01%	1719